MedPath

Comparative Study of Osteosynthesis for Chevron Osteotomy of Hallux Valgus Using Degradable Versus Non-degradable Metallic Device

Not Applicable
Completed
Conditions
Hallux Valgus
Registration Number
NCT01535144
Lead Sponsor
Syntellix AG
Brief Summary

The purpose of the study is to show the equivalence of a new degradable metallic device to a non-degradable metallic device in patients with Hallux Valgus.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Female and male patients with an age of 40 to 79 years at the day of surgery
  • Symptomatic Hallux Valgus
  • Radiological criterium area of proximal joint angle
  • Normal motorically functions
  • Female patients of childbearing age must be using two reliable contraception methods
Exclusion Criteria
  • Previous bone and/or soft tissue surgeries of the the first metatarsal of the respective foot
  • BMI > 32
  • Cysts of the first metatarsal of the respective foot
  • Neurological disorders with modified motorically functions
  • Clinical evidence of osteoporosis
  • Chronic renal impairment
  • Known hypersensitivity to components of the implants
  • Regular administration of medications containing the metallic elements of the degradable implant
  • Pregnant or lactating women
  • Current participation in another clinical trial or within 30 days before surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
difference of metatarsal angles in degree post surgery and 6 months after surgeryup to 6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinic for Orthopaedic Surgery (in the Annastift Hospital)

🇩🇪

Hanover, Lower Saxony, Germany

Clinic for Orthopaedic Surgery (in the Annastift Hospital)
🇩🇪Hanover, Lower Saxony, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.